NEW YORK – The Pancreatic Cancer Action Network (PanCAN) has launched an adaptive clinical trial platform, called Precision Promise, that allows investigators to evaluate more than one experimental therapy at the same time.
NEW YORK – The Pancreatic Cancer Action Network (PanCAN) has launched an adaptive clinical trial platform, called Precision Promise, that allows investigators to evaluate more than one experimental therapy at the same time.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.